FUJIFILM Pharmaceuticals U.S.A., Inc. is a clinical development company serving as Fujifilm's global center for new drug development. FUJIFILM Group is developing a wide variety of new drugs from small molecules to biologics by applying proprietary technologies harnessed through its long-standing operations in photographic films.
We conduct clinical trials in conjunction with medical institutions and industry partners that boast a wealth of both innovative ideas and experience. In this manner, we work to maximize efficiency of the development so that we can deliver innovative drugs to the broader population of the patients worldwide at reasonable cost.
FUJIFILM Pharmaceutical U.S.A., Inc. is a wholly owned U.S. subsidiary of FUJIFILM Holdings America Corporation.